Evidence map›Paper›PMID 29030347›Full record

ArticleCirculation2018

Extracellular Matrix Proteomics Reveals Interplay of Aggrecan and Aggrecanases in Vascular Remodeling of Stented Coronary Arteries.

Gonca Suna, Wojciech Wojakowski, Marc Lynch, Javier Barallobre-Barreiro, Xiaoke Yin, Ursula Mayr, Ferheen Baig, Ruifang Lu, Marika Fava, Robert Hayward and 11 more

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Circulation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 3 pooled it
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 3 syntheses or guidelines pooled it, 104 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Aortic Stenosis Hyalectan Remodeling Revealed by Proteomics and Glycoproteomics.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Transcriptomic and Multi-scale Network Analyses Reveal Key Drivers of Cardiovascular Disease.IEEE transactions on molecular, biological, and multi-scale communications · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 2 countries.

Gonca SunaKing's British Heart Foundation Centre, King's College London, United Kingdom (G.S., M.L., J.B.-B., X.Y., U.M., F.B., R.L., M.F., R.H., C.M., C.M.S., M.M.).
Wojciech Wojakowski3rd Division of Cardiology, Medical University of Silesia, Katowice, Poland (W.W., T.R., P.G.).
Marc LynchKing's British Heart Foundation Centre, King's College London, United Kingdom (G.S., M.L., J.B.-B., X.Y., U.M., F.B., R.L., M.F., R.H., C.M., C.M.S., M.M.).
Javier Barallobre-BarreiroKing's British Heart Foundation Centre, King's College London, United Kingdom (G.S., M.L., J.B.-B., X.Y., U.M., F.B., R.L., M.F., R.H., C.M., C.M.S., M.M.).
Xiaoke YinKing's British Heart Foundation Centre, King's College London, United Kingdom (G.S., M.L., J.B.-B., X.Y., U.M., F.B., R.L., M.F., R.H., C.M., C.M.S., M.M.).
Ursula MayrKing's British Heart Foundation Centre, King's College London, United Kingdom (G.S., M.L., J.B.-B., X.Y., U.M., F.B., R.L., M.F., R.H., C.M., C.M.S., M.M.).
Ferheen BaigKing's British Heart Foundation Centre, King's College London, United Kingdom (G.S., M.L., J.B.-B., X.Y., U.M., F.B., R.L., M.F., R.H., C.M., C.M.S., M.M.).
Ruifang LuKing's British Heart Foundation Centre, King's College London, United Kingdom (G.S., M.L., J.B.-B., X.Y., U.M., F.B., R.L., M.F., R.H., C.M., C.M.S., M.M.).
Marika FavaKing's British Heart Foundation Centre, King's College London, United Kingdom (G.S., M.L., J.B.-B., X.Y., U.M., F.B., R.L., M.F., R.H., C.M., C.M.S., M.M.).
Robert HaywardKing's British Heart Foundation Centre, King's College London, United Kingdom (G.S., M.L., J.B.-B., X.Y., U.M., F.B., R.L., M.F., R.H., C.M., C.M.S., M.M.).
Chris MolenaarKing's British Heart Foundation Centre, King's College London, United Kingdom (G.S., M.L., J.B.-B., X.Y., U.M., F.B., R.L., M.F., R.H., C.M., C.M.S., M.M.).
Stephen J WhiteHealthcare Science Research Centre, Manchester Metropolitan University, United Kingdom (S.J.W.).
Tomasz Roleder3rd Division of Cardiology, Medical University of Silesia, Katowice, Poland (W.W., T.R., P.G.).
Krzysztof P MilewskiCentre for Cardiovascular Research and Development, American Heart of Poland, Katowice (K.P.M., P.P.B., P.B.).
Pawel Gasior3rd Division of Cardiology, Medical University of Silesia, Katowice, Poland (W.W., T.R., P.G.).
Piotr P BuszmanCentre for Cardiovascular Research and Development, American Heart of Poland, Katowice (K.P.M., P.P.B., P.B.).
Pawel BuszmanCentre for Cardiovascular Research and Development, American Heart of Poland, Katowice (K.P.M., P.P.B., P.B.).
Marjan JahangiriSt George's Vascular Institute, St George's Healthcare NHS Trust, London, United Kingdom (M.J.).
Catherine M ShanahanKing's British Heart Foundation Centre, King's College London, United Kingdom (G.S., M.L., J.B.-B., X.Y., U.M., F.B., R.L., M.F., R.H., C.M., C.M.S., M.M.).
Jonathan HillKing's College Hospital and King's Health Partners Academic Health Sciences, London, United Kingdom (J.H.).
Manuel MayrKing's British Heart Foundation Centre, King's College London, United Kingdom (G.S., M.L., J.B.-B., X.Y., U.M., F.B., R.L., M.F., R.H., C.M., C.M.S., M.M.) manuel.mayr@kcl.ac.uk.
British Heart Foundation · GBKing's College London · GBAmerican Heart of Poland · PLMedical University of Silesia · PLManchester Metropolitan University · GBSt George’s University Hospitals NHS Foundation Trust · GB

Funding

British Heart Foundation CH/16/3/32406British Heart Foundation FS/13/2/29892British Heart Foundation PG/17/48/32956British Heart Foundation RG/11/14/29056British Heart Foundation RG/16/14/32397British Heart Foundation RG/17/2/32808
6 · The paper itself

Abstract

backgroundExtracellular matrix (ECM) remodeling contributes to in-stent restenosis and thrombosis. Despite its important clinical implications, little is known about ECM changes post-stent implantation.

methodsBare-metal and drug-eluting stents were implanted in pig coronary arteries with an overstretch under optical coherence tomography guidance. Stented segments were harvested 1, 3, 7, 14, and 28 days post-stenting for proteomics analysis of the media and neointima.

resultsA total of 151 ECM and ECM-associated proteins were identified by mass spectrometry. After stent implantation, proteins involved in regulating calcification were upregulated in the neointima of drug-eluting stents. The earliest changes in the media were proteins involved in inflammation and thrombosis, followed by changes in regulatory ECM proteins. By day 28, basement membrane proteins were reduced in drug-eluting stents in comparison with bare-metal stents. In contrast, the large aggregating proteoglycan aggrecan was increased. Aggrecanases of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family contribute to the catabolism of vascular proteoglycans. An increase in ADAMTS-specific aggrecan fragments was accompanied by a notable shift from

conclusionsSignificant differences were identified by proteomics in the ECM of coronary arteries after bare-metal and drug-eluting stent implantation, most notably an upregulation of aggrecan, a major ECM component of cartilaginous tissues that confers resistance to compression. The accumulation of aggrecan coincided with a shift in

Indexed as

AggrecansStentsVascular RemodelingADAMTS5 ProteinADAMTS ProteinsAnimalsChromatography, High Pressure LiquidCoronary VesselsDrug-Eluting StentsEndopeptidasesExtracellular MatrixFemaleHumansMaleMetalsMice, KnockoutADAMTS5 ProteinAdamts5 protein, mouseADAMTS ProteinsaggrecanaseAggrecansEndopeptidasesMetalscoronary arterydiseaseextracellular matrixmass spectrometryneointimastents

Identifiers

PMID29030347
PMCPMC5757669
OpenAlexW2762363211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.